We have received all of the results but won't know all of the details until his appointment on the 8th.
The bone mets are blastic affecting the following areas: sternum, bilateral ribs, multiple levels of the spine (primarily L3), multiple areas in the pelvis (primarily the right iliac), right and left femur and left humerus.
Multiple lymph node involvement not including the mass on his neck:
- 1 cm portocaval node (2:52)
-2 cm para-aortic node (2:71)
-2.6 cm aortocaval node (2:90)
-1.9 cm left common iliac node (2:8)
-1.5 and 1.4 cm presacral nodes (2:118)
-1.4 cm right internal iliac node (2:127)
-3.1 cm right external iliac node (2:130)
-9 mm right inguinal node (2:172)
The pathology they ran from his surgical biopsy leaves me feeling uneasy and unsure. How would you interpret the findings. They are diagnosing it as a poorly differentiated metastatic adenocarcinoma. What about
these markers? No mention of what they think about
them (very vague). I will wait until his appointment but should we be seeking a 3rd opinion. Of course I am overly concerned. I want to be sure his treatment is appropriate for what we will be up against. Here are the results from their pathologist:
Histologic sections revealed an adenocarcinoma composed of uniform round cells arranged in cohesive cribriform structures. Provided
immunohistochemical stains show that the lesional cells are positive for
pan-cytokeratin and PSA but largely negative for p63, CK20, TTF-1, HMB-45, CK5/6, CA19-9, LCA, CK7, and CDX-2. Synaptophysin and chromogranin highlight rare cells of uncertain significance. The overall findings are most consistent with poorly differentiated metastatic adenocarcinoma of prostatic origin.
Thank you all for lifting me up when it feels like everything is caving in!
With HOPE,
Nikki
Post Edited (Bird8) : 5/2/2017 4:09:54 PM (GMT-6)